A detailed history of Virtus ETF Advisers LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 54,216 shares of PGEN stock, worth $40,662. This represents 0.02% of its overall portfolio holdings.

Number of Shares
54,216
Previous 53,250 1.81%
Holding current value
$40,662
Previous $84,000 39.29%
% of portfolio
0.02%
Previous 0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.91 - $1.88 $879 - $1,816
966 Added 1.81%
54,216 $51,000
Q2 2024

Aug 14, 2024

SELL
$1.27 - $1.75 $19,702 - $27,149
-15,514 Reduced 22.56%
53,250 $84,000
Q1 2024

May 15, 2024

SELL
$1.21 - $1.75 $5,702 - $8,247
-4,713 Reduced 6.41%
68,764 $99,000
Q4 2023

Feb 15, 2024

SELL
$0.89 - $1.41 $5,586 - $8,850
-6,277 Reduced 7.87%
73,477 $98,000
Q3 2023

Nov 07, 2023

SELL
$1.08 - $1.85 $8,573 - $14,685
-7,938 Reduced 9.05%
79,754 $113,000
Q2 2023

Aug 14, 2023

BUY
$0.96 - $1.4 $27,381 - $39,930
28,522 Added 48.2%
87,692 $100,000
Q1 2023

May 15, 2023

SELL
$0.88 - $2.19 $20,012 - $49,804
-22,742 Reduced 27.76%
59,170 $62,000
Q4 2022

Feb 14, 2023

SELL
$1.27 - $2.26 $4,706 - $8,375
-3,706 Reduced 4.33%
81,912 $124,000
Q3 2022

Nov 14, 2022

BUY
$1.41 - $2.79 $871 - $1,724
618 Added 0.73%
85,618 $182,000
Q2 2022

Aug 12, 2022

BUY
$1.15 - $2.53 $47,232 - $103,912
41,072 Added 93.5%
85,000 $114,000
Q1 2022

May 16, 2022

SELL
$1.91 - $3.98 $4,971 - $10,359
-2,603 Reduced 5.59%
43,928 $93,000
Q4 2021

Feb 14, 2022

BUY
$3.53 - $5.5 $57,828 - $90,101
16,382 Added 54.34%
46,531 $173,000
Q3 2021

Nov 15, 2021

SELL
$4.99 - $6.55 $7,884 - $10,349
-1,580 Reduced 4.98%
30,149 $150,000
Q2 2021

Aug 10, 2021

SELL
$6.24 - $8.22 $4,979 - $6,559
-798 Reduced 2.45%
31,729 $207,000
Q1 2021

May 17, 2021

BUY
$6.74 - $10.95 $3,808 - $6,186
565 Added 1.77%
32,527 $224,000
Q4 2020

Feb 12, 2021

BUY
$3.75 - $10.56 $119,857 - $337,518
31,962 New
31,962 $326,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $156M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.